Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia
Clinical trial NCT06547866 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06547866
- Sponsor
- French Innovative Leukemia Organisation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2028-12-31
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.